CN Patent

CN102250084A — 达沙替尼多晶型物及其制备方法和药用组合物

Assigned to Nanjing Cavendish Bio Engineering Technology Co Ltd · Expires 2011-11-23 · 14y expired

What this patent protects

本发明公开了达沙替尼的多晶型物，此外，本发明还公开了其制备方法和药物组合物。本发明所提供的达沙替尼多晶型物具有理化性质优异、稳定性好、更适于工业化规模制备等优点。

USPTO Abstract

本发明公开了达沙替尼的多晶型物，此外，本发明还公开了其制备方法和药物组合物。本发明所提供的达沙替尼多晶型物具有理化性质优异、稳定性好、更适于工业化规模制备等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN102250084A
Jurisdiction
CN
Classification
—
Expires
2011-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Cavendish Bio Engineering Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.